STAT3 and cancer: The molecular mechanism of CXCR2 in cancer progression may include various signaling pathways such as mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K), signal transducer and activator of transcription 3 (STAT3) and NF-κB pathways [16].